サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514974

RNAベース治療薬およびワクチン市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

RNA-based Therapeutics and Vaccines Market, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 262 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
RNAベース治療薬およびワクチン市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 262 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

RNAベース治療薬およびワクチン市場規模は2023年に200万米ドルと評価され、2024年から2032年にかけてCAGR 65.10%で拡大

RNAベース治療薬およびワクチン市場-市場力学

RNA送達技術と個別化医療の進歩が市場需要を促進すると予測

mRNA治療などのRNAベースの治療薬は、個別化医療に有望です。RNAベースの治療薬は、個々の患者に特有の遺伝子変異や疾患メカニズムをターゲットとして調整することができます。このようなカスタマイズの可能性は、個人の遺伝子プロファイルや疾患の特徴に合わせて治療を行う精密医療に向けた動向の高まりと一致しています。このように、個別化治療・医療に対する需要の増加は、市場の成長を促進すると予想されます。さらに、脂質ナノ粒子（LNP）やその他の送達システムの進歩により、RNA治療薬やワクチンの安定性と効率が大幅に向上しています。こうした進歩は商業化への障壁を減らし、さまざまな疾患に対するRNAベースの治療の実現可能性を高めています。

COVID-19パンデミックは、迅速なワクチン開発の緊急性を浮き彫りにしました。ファイザー・バイオNTech社やModerna社が開発したようなRNAベースのワクチンは、前例のないスピードで開発と展開が行われました。この経験は、将来のパンデミック対策に向けたRNA技術への関心と投資を加速させました。FDAやEMAなどの規制機関は、特に公衆衛生上の緊急事態の際には、RNAベースの治療法やワクチンの審査プロセスを迅速化する意向を示しています。このような規制当局の支援は、市場投入までの時間を短縮し、RNA技術へのさらなる投資を促します。

RNAベース治療薬およびワクチン市場-主要な洞察

リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約65.10%のCAGRで年間成長すると予測されます。

製品タイプ別では、RNA治療薬のニーズが高いことから、RNAベースの治療薬分野が2023年に最大の市場シェアを示すと予測されています。

用途別では、心血管疾患治療におけるRNAワクチン需要の高まりにより、心血管疾患分野が2023年の主要用途でした。

エンドユーザーセグメントに基づくと、慢性疾患、遺伝性疾患、心血管疾患の治療に対する高い需要により、2023年には病院セグメントが主要エンドユーザーとなった。

地域別では、感染症や遺伝性疾患の有病率の高さから、北米が2023年に収益でリードしました。

RNAベース治療薬およびワクチン市場-セグメンテーション分析：

RNAベース治療薬およびワクチンの世界市場は、製品タイプ、用途、エンドユーザー、地域に基づいて区分されます。

市場は製品タイプによって2つのカテゴリーに分けられる：RNAベースの治療薬とRNAベースのワクチンです。RNAベースのワクチンは市場を独占しています。精密医薬品ワクチン＆治療に対する需要の高さが市場成長を後押ししています。

市場は用途別に7つのカテゴリーに分類される：腫瘍学、免疫学、眼科学、感染症、心血管疾患、遺伝病、その他。心血管疾患分野が市場を独占しています。遺伝学と免疫学に関連する疾患の増加と遺伝学の新しい研究が、このセグメントの需要を促進しています。

市場はエンドユーザー別に病院・診療所、研究所、その他の3つに分類されます。病院・診療所セグメントは市場を独占しており、予測期間中も高い優位性を維持すると予想されます。研究室は、ワクチン研究と治療の増加により、最も速い速度で拡大すると予想されます。

RNAベース治療薬およびワクチン市場-地理的洞察

RNAベースの治療薬・ワクチン市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米が世界市場を独占しています。先駆的なRNAベースの治療薬やワクチンの多くは、この地域に拠点を置く企業から生まれており、強力な研究機関やベンチャーキャピタルからの資金提供によって支えられています。米国FDAがRNAベースの治療法の開発と認可を促進する積極的な姿勢を示していることが、米国での投資を促し、商業化を加速させています。

RNAベース治療薬およびワクチン市場-競合情勢：

RNAベースの治療薬・ワクチン市場は、複数の主要企業による激しい競争が特徴です。市場参入企業は、がん、遺伝性疾患、感染症、代謝性疾患など、幅広い疾患においてRNAベースの治療を積極的に進めています。現在進行中の臨床試験と前臨床研究は、RNA技術の治療応用をCOVID-19パンデミック以外にも拡大することを目指しています。アカデミア、バイオテクノロジー企業、製薬会社のコラボレーションが、RNAベースの治療法におけるイノベーションを推進しています。これらのパートナーシップは、RNA生物学、ドラッグデリバリー、臨床開発における多様な専門知識を活用し、研究の商業製品への転換を加速しています。

目次

第1章 RNAベース治療薬およびワクチン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 RNAベース治療薬およびワクチンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 RNAベース治療薬およびワクチン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 RNAベース治療薬およびワクチン市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 RNAベース治療薬およびワクチンの市場情勢

  • RNAベース治療薬およびワクチンの市場シェア分析、2024年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 RNAベース治療薬およびワクチン市場：製品タイプ別

  • 概要
    • セグメントシェア分析
    • RNAベースの治療薬
    • RNAベースのワクチン

第8章 RNAベース治療薬およびワクチン市場：用途別

  • 概要
    • セグメントシェア分析
    • 腫瘍学
    • 免疫学
    • 眼科
    • 感染症
    • 循環器疾患
    • 遺伝性疾患
    • その他

第9章 RNAベース治療薬およびワクチン市場：エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 病院・クリニック
    • 研究ラボ
    • その他

第10章 RNAベース治療薬およびワクチン市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：RNAベース治療薬およびワクチン業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Moderna, Inc.
    • Pfizer-BioNTech
    • CureVac
    • Alnylam Pharmaceuticals
    • Arrowhead Pharmaceuticals
    • Translate Bio
    • BioNTech SE
    • Dicerna Pharmaceuticals
    • Regulus Therapeutics
    • Ionis Pharmaceuticals
    • Sirnaomics
    • Marina Biotech
    • Sarepta Therapeutics
    • Arcturus Therapeutics
    • AstraZeneca
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE RNA-based Therapeutics and Vaccines Market: Product Type Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global RNA-based Therapeutics and Vaccines Market, by Product Type 2019-2032 (USD Million)
  • TABLE RNA-based Therapeutics and Vaccines Market: Application Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global RNA-based Therapeutics and Vaccines Market, by Application 2019-2032 (USD Million)
  • TABLE RNA-based Therapeutics and Vaccines Market: End User Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global RNA-based Therapeutics and Vaccines Market, by End User 2019-2032 (USD Million)
  • TABLE RNA-based Therapeutics and Vaccines Market: Regional snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global RNA-based Therapeutics and Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE North America RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE RNA-based Therapeutics and Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2024
  • FIGURE Product Type segment market share analysis, 2024 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2024 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2024 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2024 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE Europe RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE Asia Pacific RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE Latin America RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE Middle East and Africa RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE North America market share analysis by country, 2024
  • FIGURE U.S. RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
  • FIGURE Germany RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
  • FIGURE India RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philipines RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
  • FIGURE Brazil RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
  • FIGURE Saudi Arabia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3080

REPORT HIGHLIGHT

The RNA-based Therapeutics and Vaccines Market size was valued at USD 2.0 Million in 2023, expanding at a CAGR of 65.10% from 2024 to 2032.

RNA-based therapeutics and vaccines represent a modern approach to medical treatments and disease prevention that utilizes RNA molecules as the primary agents for therapy or immunization. RNA vaccines can be developed and manufactured more rapidly than traditional vaccines, as they do not require the production of the pathogen itself.

RNA-based Therapeutics and Vaccines Market- Market Dynamics

Advancement in RNA delivery technologies and personalized medicines are expected to propel market demand

RNA-based therapeutics, such as mRNA therapy, hold promise for personalized medicine. They can be tailored to target specific genetic mutations or disease mechanisms unique to individual patients. This potential for customization aligns with the growing trend toward precision medicine, where treatments are increasingly tailored to individual genetic profiles and disease characteristics. Thus, increased demand for personalized therapies & medicine is expected to fuel the market growth. Additionally, advances in lipid nanoparticles (LNPs) and other delivery systems have significantly improved the stability and efficiency of RNA therapeutics and vaccines. These advancements reduce barriers to commercialization and enhance the feasibility of RNA-based treatments for various diseases.

The COVID-19 pandemic has underscored the urgent need for rapid vaccine development. RNA-based vaccines, such as those developed by Pfizer-BioNTech and Moderna, demonstrated unprecedented speed in development and deployment. This experience has accelerated interest and investment in RNA technology for future pandemic preparedness. Regulatory agencies, such as the FDA and EMA, have demonstrated willingness to expedite review processes for RNA-based therapies and vaccines, particularly during public health emergencies. This regulatory support reduces time to market and encourages further investment in RNA technology.

RNA-based Therapeutics and Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 65.10% over the forecast period (2024-2032)

Based on Product Type segmentation, the RNA-based Therapeutics segment was predicted to show maximum market share in the year 2023, owing to the high need for RNA therapeutics.

Based on Application segmentation, cardiovascular diseases segment was the leading Application in 2023, owing to rising demand for RNA vaccines in treatment of cardiovascular diseases.

Based on End User segmentation, hospitals segment was the leading End User in 2023, owing to high demand for treatment of chronic, genetic, and cardiovascular disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to high prevalence of infectious & genetic diseases.

RNA-based Therapeutics and Vaccines Market- Segmentation Analysis:

The Global RNA-based Therapeutics and Vaccines Market is segmented on the basis of Product Type, Application, End User, and Region.

The market is divided into two categories based on Product Type: RNA-based Therapeutics and RNA-based Vaccines. The RNA-based Vaccines segment dominates the market. High demand for precision medicinal vaccines & therapies are boosting market growth.

The market is divided into seven categories based on the Application: oncology, immunology, ophthalmology, infectious disease, cardiovascular disease, genetic disease, and others. The cardiovascular disease segment dominates the market. Rising genetic and immunology related diseases and new research in genetics is promoting segment demand.

The market is divided into three categories based on End User: hospitals & clinics, research laboratories, and others. The hospitals & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. Research laboratories is expected to expand at fastest rate with rise in vaccine research & therapies.

RNA-based Therapeutics and Vaccines Market- Geographical Insights

Worldwide, the RNA-based Therapeutics and Vaccines market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global market. Many pioneering RNA-based therapeutics and vaccines originate from companies based in this region, supported by robust research institutions and venture capital funding. The US FDA's proactive stance on facilitating the development and approval of RNA-based therapies has encouraged investment and accelerated commercialization in the United States.

RNA-based Therapeutics and Vaccines Market- Competitive Landscape:

The market for RNA-based therapeutics and vaccines is characterized by intense competition among several key companies. Market players are actively advancing RNA-based therapies across a wide range of diseases, including cancer, genetic disorders, infectious diseases, and metabolic conditions. Ongoing clinical trials and preclinical research aim to expand the therapeutic applications of RNA technologies beyond the COVID-19 pandemic. Collaborations between academia, biotech firms, and pharmaceutical companies are driving innovation in RNA-based therapies. These partnerships leverage diverse expertise in RNA biology, drug delivery, and clinical development to accelerate the translation of research into commercial products.

Recent Developments:

In August 2023, CureVac collaborated with GSK for the development of bivalent mRNA COVID-19 vaccines.

In March 2022, Moderna has started second phase HIV vaccine trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET KEY PLAYERS

  • Moderna, Inc.
  • Pfizer-BioNTech
  • CureVac
  • Alnylam Pharmaceuticals
  • Arrowhead Pharmaceuticals
  • Translate Bio
  • BioNTech SE
  • Dicerna Pharmaceuticals
  • Regulus Therapeutics
  • Ionis Pharmaceuticals
  • Sirnaomics
  • Marina Biotech
  • Sarepta Therapeutics
  • Arcturus Therapeutics
  • AstraZeneca
  • Others

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • RNA-based Therapeutics
  • RNA-based Vaccines

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Oncology
  • Immunology
  • Ophthalmology
  • Infectious disease
  • Cardiovascular disease
  • Genetic disease
  • Others

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital & Clinics
  • Research Laboratories
  • Others

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. RNA-based Therapeutics and Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. RNA-based Therapeutics and Vaccines Market Snippet by Product Type
    • 2.1.2. RNA-based Therapeutics and Vaccines Market Snippet by Application
    • 2.1.3. RNA-based Therapeutics and Vaccines Market Snippet by End User
    • 2.1.4. RNA-based Therapeutics and Vaccines Market Snippet by Country
    • 2.1.5. RNA-based Therapeutics and Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. RNA-based Therapeutics and Vaccines Key Market Trends

  • 3.1. RNA-based Therapeutics and Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. RNA-based Therapeutics and Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. RNA-based Therapeutics and Vaccines Market Opportunities
  • 3.4. RNA-based Therapeutics and Vaccines Market Future Trends

4. RNA-based Therapeutics and Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. RNA-based Therapeutics and Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. RNA-based Therapeutics and Vaccines Market Landscape

  • 6.1. RNA-based Therapeutics and Vaccines Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. RNA-based Therapeutics and Vaccines Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. RNA-based Therapeutics
    • 7.1.3. RNA-based Vaccines

8. RNA-based Therapeutics and Vaccines Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Immunology
    • 8.1.4. Ophthalmology
    • 8.1.5. Infectious disease
    • 8.1.6. Cardiovascular disease
    • 8.1.7. Genetic disease
    • 8.1.8. Others

9. RNA-based Therapeutics and Vaccines Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital & Clinics
    • 9.1.3. Research Laboratories
    • 9.1.4. Others

10. RNA-based Therapeutics and Vaccines Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. RNA-based Therapeutics and Vaccines Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- RNA-based Therapeutics and Vaccines Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Moderna, Inc.
    • 11.2.2. Pfizer-BioNTech
    • 11.2.3. CureVac
    • 11.2.4. Alnylam Pharmaceuticals
    • 11.2.5. Arrowhead Pharmaceuticals
    • 11.2.6. Translate Bio
    • 11.2.7. BioNTech SE
    • 11.2.8. Dicerna Pharmaceuticals
    • 11.2.9. Regulus Therapeutics
    • 11.2.10. Ionis Pharmaceuticals
    • 11.2.11. Sirnaomics
    • 11.2.12. Marina Biotech
    • 11.2.13. Sarepta Therapeutics
    • 11.2.14. Arcturus Therapeutics
    • 11.2.15. AstraZeneca
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us